Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its ...
The partnership between the American University in Cairo (AUC) and Minapharm Pharmaceuticals, which gets underway early this year, will contribute to establishing what the university describes as the ...
Andrew Hillman today announces the launch of the Andrew Hillman Grant for Biotech, a program designed to assist undergraduate ...
11don MSN
NITI Aayog Report Praises Gujarat Biotechnology University At GIFT City As A Global Education Model
Gandhinagar: A recent NITI Aayog report on the globalisation of higher education has praised the Gujarat government's ...
17hon MSN
Indiana colleges already nixed hundreds of degrees. This national group's push could risk more
More Indiana college degree programs could be at risk amid an ongoing national battle over the future of higher education.
The University of Birmingham is set to launch degrees in Bangkok and Thailand’s Eastern Economic Corridor, alongside the ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the expansion of its gastrointestinal ("GI") ...
EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies ...
Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...
ProBioGen has signed a Master Service Agreement with Zag Bio Inc., a biotechnology company developing thymus-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results